Diagnosis of genetic disease by primer-specified restriction map modification, with application to cystic fibrosis and retinitis pigmentosa
- 11 May 1991
- journal article
- Published by Elsevier in The Lancet
- Vol. 337 (8750) , 1115-1118
- https://doi.org/10.1016/0140-6736(91)92785-z
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Characterization of polymerase chain reaction amplification of specific allelesAnalytical Biochemistry, 1990
- Mutation Analysis for Heterozygote Detection and the Prenatal Diagnosis of Cystic FibrosisNew England Journal of Medicine, 1990
- PCR test for cystic fibrosis deletionNature, 1990
- Effects of primer-template mismatches on the polymerase chain reaction: Human immunodeficiency virus type 1 model studiesNucleic Acids Research, 1990
- A point mutation of the rhodopsin gene in one form of retinitis pigmentosaNature, 1990
- Modification of enzymatic-ally amplified DNA for the detection of point mutationsNucleic Acids Research, 1989
- Diagnosis of Sickle Cell Anemia and β-Thalassemia with Enzymatically Amplified DNA and Nonradioactive Allele-Specific Oligonucleotide ProbesNew England Journal of Medicine, 1988
- Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probesNature, 1986
- Isolation and nucleotide sequence of the gene encoding human rhodopsin.Proceedings of the National Academy of Sciences, 1984